Trials / Conditions / Fragile X Syndrome (FXS)

Fragile X Syndrome (FXS)

11 registered clinical trials studyying Fragile X Syndrome (FXS) — 5 currently recruiting.

Status	Trial	Sponsor	Phase
Recruiting	Optical Imaging in X-linked Disorders. NCT06868979	Hospices Civils de Lyon	N/A
Recruiting	Intensive Multimodal Neurorehabilitation Targeting Neuroplasticity in Pediatric Neurodevelopmental and Chromos NCT07493096	Healing Hope International	—
Not Yet Recruiting	A Study to Investigate the Effects and Safety of SPG601 for the Treatment of Fragile X Syndrome in Male Partic NCT07439510	Spinogenix	Phase 2 / Phase 3
Not Yet Recruiting	The Neurocognitive Bases of Trust in Intellectual Disability NCT07434037	Hospices Civils de Lyon	—
Completed	Neural Biomarkers in Fragile X Syndrome NCT06957054	Connecta Therapeutics, S.L.	—
Recruiting	Group CBT in Adolescents With Fragile X Syndrome and in Adolescents With Autism Spectrum Disorder NCT06677866	Bambino Gesù Hospital and Research Institute	N/A
Withdrawn	Novel Clinical Target in Fragile X Syndrome NCT04314856	Guido A. Davidzon, MD, SM	Phase 1
Completed	A Study of OV101 in Individuals With Fragile X Syndrome NCT03697161	Healx AI	Phase 2
Terminated	Neuroimaging GABA Physiology in Fragile X Syndrome NCT04308954	Stanford University	Phase 1
Completed	Glutaminergic Transmission in Autism : Molecular Imaging Exploration NCT02719951	University Hospital, Tours	Phase 1
Completed	Decisional Capacity and Informed Consent in Fragile X Syndrome NCT02465931	RTI International	N/A